Development of BET inhibitors as potential treatments for cancer: A new carboline chemotype-Reference-Cited by-同舟云学术

Development of BET inhibitors as potential treatments for cancer: A new carboline chemotype

Published:2021-11 Issue: Volume:51 Page:128376
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Hill Matthew D.^ORCID,Quesnelle Claude,Tokarski John,Fang Haiquan,Fanslau Carolynn,Haarhoff Zuzana,Kramer Melissa,Madari Shilpa,Wiebesiek Amy,Morrison John,Simmermacher-Mayer Jean,Sinz Michael,Westhouse Richard,Xie Chunshan,Zhao Jiuqiao,Huang Lisa,Sheriff Steven^ORCID,Yan Chunhong,Marsilio Frank,Everlof Gerry,Zvyaga Tatyana,Lee Francis,Gavai Ashvinikumar V.,Degnan Andrew P.^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference29 articles.

1. Strategies to Inhibit Myc and Their Clinical Applicability

2. BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

3. Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers

4. Place your BETs: the therapeutic potential of bromodomains

5. Small Molecule Bromodomain Inhibitors

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The anti‐breast cancer therapeutic potential of 1,2,3‐triazole‐containing hybrids;Archiv der Pharmazie;2023-12-18

2. Recent updates on 1,2,3-triazole-containing hybrids with in vivo therapeutic potential against cancers: A mini-review;European Journal of Medicinal Chemistry;2023-05

3. Epigenetic alterations in canine mammary cancer;Genetics and Molecular Biology;2022